Stay updated on Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The study record view is replaced by a 403 Forbidden message with a Home link. The NIH transition announcement banner is also no longer shown.
    Difference
    2%
    Check dated 2026-11-08T12:31:49.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer now identifies the site release as v3.8.0 instead of v3.7.2, while the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T13:13:47.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A notice about NIH’s transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page.
    Difference
    1%
    Check dated 2026-10-25T13:16:54.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T14:11:29.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The site footer revision number changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T13:57:53.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Page revision updated to v3.7.0 and older study documents/history entries were removed, reflecting a cleanup of the study record rather than changes to the study's current details.
    Difference
    19%
    Check dated 2026-09-20T20:12:35.000Z thumbnail image

Stay in the know with updates to Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial page.